G. I. Kulik

Role of DNA hypomethylation in the development of the resistance to doxorubicin in human MCF-7 breast adenocarcinoma cells.

I. Pogribny, O. Yurchenko, V. Tryndyak, 2006, Cancer letters.

RESISTANCE OF GUERIN S CARCINOMA CELLS TO CISPLATINE : BIOCHEMICAL AND MORPHOLOGICAL ASPECTS

O. Yurchenko, V. Tryndyak, V. Chekhun, 2022 .

Biodistribution analysis of cisplatin in liposomal form in animals with cisplatin-resistant and cisplatin-sensitive carcinoma.

V. Chekhun, I. Todor, G. Solyanik, 2010, Experimental oncology.

Experimental determination of individual sensitivity of tumors to alkylating compounds with antitumor action

G. I. Kulik, 1969, Bulletin of Experimental Biology and Medicine.

IMMUNOHISTOCHEMICAL STUDIES OF CD 150 EXPRESSION IN SOME HUMAN TUMORS

O. Yurchenko, M. Yurchenko, S. P. Sidorenko, 2004 .

[Influence of tumor drug resistance phenotype on the dynamics of cisplatin-induced changes of rat peripheral lymphocyte chromatin structure in Guerin's carcinoma].

K. Ganina, V. Chekhun, G. I. Kulik, 2000, TSitologiia i genetika.

The SEIRA spectroscopy data of nucleic acids and phospholipids from sensitive- and drug-resistant rat tumours.

O. P. Repnytska, V. P. Tryndiak, G. Dovbeshko, 2002, Journal of experimental & clinical cancer research : CR.

Different growth patterns of a cancer cell population as a function of its starting growth characteristics: analysis by mathematical modelling

G I Solyanik, N M Berezetskaya, R I Bulkiewicz, 1995, Cell proliferation.

The role of expression of the components of proteome in the formation of molecular profile of human ovarian carcinoma A2780 cells sensitive and resistant to cisplatin.

V. Chekhun, N. Lukyanova, G. I. Kulik, 2005, Experimental oncology.